跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
RUXIENCE Rituximab 500mg/ 50mL concentrated solution for injection vial
Approved
STANDARD
RUXIENCE Rituximab 500mg/ 50mL concentrated solution for injection vial
Pfizer Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
297ed52546aecb06
Company
Pfizer Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
297ed52546aecb06
Product Name
RUXIENCE Rituximab 500mg/ 50mL concentrated solution for injection vial
Artg Id
330536
Artg Name
RUXIENCE Rituximab 500mg/ 50mL concentrated solution for injection vial
Sponsor
Pfizer Australia Pty Ltd
Company Detail Path
/organization/pfizer-australia-pty-ltd
Artg Date
2021-03-03
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
297ed52546aecb06
Type
Standard
Back to TGA Approvals
RUXIENCE Rituximab 500mg/ 50mL concentrated solution for injection vial - TGA Drug Approval Details
